Norifumi Ishikawa

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Yasuhide Yamada, T. Doi, B. Hewes, 2017, Cancer science.

Abstract B31: A Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors

T. Doi, B. Hewes, T. Tajima, 2015 .

A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma

M. Taniwaki, S. Iida, H. Minami, 2021, International Journal of Hematology.